Genomic mechanisms and measurement of structural and numerical instability in cancer cells

Seminars in Cancer Biology

Volumn 17, Issue 1, 2007, Pages 5-18

  Bayani, Jane ^a   Selvarajah, Shamini ^b   Maire, Georges ^a   Vukovic, Bisera ^c   Al Romaih, Khaldoun ^c   Zielenska, Maria ^b   Squire, Jeremy A ^a,c  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer stem cell; Cellular clonality; Chromosome architecture; DNA repair; FISH

Indexed keywords

DNA;

CANCER CELL; CANCER GROWTH; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; CYTOGENETICS; DNA METHYLATION; DNA REPAIR; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR GENETICS; POPULATION GENETICS; REVIEW; STRUCTURAL CHROMOSOME ABERRATION;

ALU ELEMENTS; ANIMALS; CELL NUCLEUS; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATIONS; CHROMOSOMES; CYTOGENETICS; DNA METHYLATION; DNA REPAIR; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MITOSIS; MODELS, GENETIC; NEOPLASMS;

EID: 33846168450     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2006.10.006     Document Type: Review

References (128)

1. Balmain A., Gray J., and Ponder B. The genetics and genomics of cancer. Nat Genet 33 Suppl (2003) 238-244
2. Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71 (1992) 543-546
3. Raptis S., and Bapat B. Genetic instability in human tumors. EXS (2006) 303-320
4. Renan M.J. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7 (1993) 139-146
5. Rajagopalan H., Nowak M.A., Vogelstein B., et al. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3 (2003) 695-701
6. Kolodner R.D. Mismatch repair: mechanisms and relationship to cancer susceptibility. Trends Biochem Sci 20 (1995) 397-401
7. Modrich P. Strand-specific mismatch repair in mammalian cells. J Biol Chem 272 (1997) 24727-24730
8. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instability in colorectal cancers. Nature 386 (1997) 623-627
9. Raghavan S.C., and Lieber M.R. DNA structures at chromosomal translocation sites. Bioessays 28 (2006) 480-494
10. Gorringe K.L., Chin S.F., Pharoah P., et al. Evidence that both genetic instability and selection contribute to the accumulation of chromosome alterations in cancer. Carcinogenesis 26 (2005) 923-930
11. Zielenska M., Zhang Z.M., Ng K., et al. Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome. Cancer 91 (2001) 2156-2164
12. Al-Romaih K., Bayani J., Vorobyova J., et al. Chromosomal instability in osteosarcoma and its association with centrosome abnormalities. Cancer Genet Cytogenet 144 (2003) 91-99
13. Shaffer L.G., and Tommerup N. An international system for human cytogenetic nomenclature (2005) (2005), Karger Publishers, Basel, Switzerland
14. Speicher M.R., and Carter N.P. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6 (2005) 782-792
15. Hughes S., Yoshimoto M., Beheshti B., et al. The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression. BMC Genomics 7 (2006) 65
16. Schrock E., Veldman T., Padilla-Nash H., et al. Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet 101 (1997) 255-262
17. Speicher M.R., Gwyn Ballard S., and Ward D.C. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12 (1996) 368-375
18. Chudoba I., Plesch A., Lorch T., et al. High resolution multicolor-banding: a new technique for refined FISH analysis of human chromosomes. Cytogenet Cell Genet 84 (1999) 156-160
19. Aplan P.D. Causes of oncogenic chromosomal translocation. Trends Genet 22 (2006) 46-55
20. Abeysinghe S.S., Chuzhanova N., Krawczak M., et al. Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat 22 (2003) 229-244
21. Chuzhanova N., Abeysinghe S.S., Krawczak M., et al. Translocation and gross deletion breakpoints in human inherited disease and cancer II: potential involvement of repetitive sequence elements in secondary structure formation between DNA ends. Hum Mutat 22 (2003) 245-251
22. Roy-Engel A.M., Salem A.H., Oyeniran O.O., et al. Active Alu element "A-tails": size does matter. Genome Res 12 (2002) 1333-1344
23. Batzer M.A., and Deininger P.L. Alu repeats and human genomic diversity. Nat Rev Genet 3 (2002) 370-379
24. Kolomietz E., Meyn M.S., Pandita A., et al. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35 (2002) 97-112
25. Kolomietz E., Al-Maghrabi J., Brennan S., et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 97 (2001) 3581-3588
26. Edelmann L., Spiteri E., Koren K., et al. AT-rich palindromes mediate the constitutional t(11;22) translocation. Am J Hum Genet 68 (2001) 1-13
27. Braude I., Vukovic B., Prasad M., et al. Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia. BMC Genomics 7 (2006) 138
28. Vig B.K., Sternes K.L., and Paweletz N. Centromere structure and function in neoplasia. Cancer Genet Cytogenet 43 (1989) 151-178
29. Mitelman F., Mertens F., and Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15 Spec No (1997) 417-474
30. Grady D.L., Ratliff R.L., Robinson D.L., et al. Highly conserved repetitive DNA sequences are present at human centromeres. Proc Natl Acad Sci USA 89 (1992) 1695-1699
31. Padilla-Nash H.M., Heselmeyer-Haddad K., Wangsa D., et al. Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms. Genes Chromosomes Cancer 30 (2001) 349-363
32. Lejeune J., Maunoury C., Prieur M., et al. A jumping translocation (5p;15q), (8q;15q), and (12q;15q) (author's transl). Ann Genet 22 (1979) 210-213
33. Sawyer J.R., Tricot G., Mattox S., et al. Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood 91 (1998) 1732-1741
34. Bayani J., Zielenska M., Pandita A., et al. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36 (2003) 7-16
35. Beheshti B., Karaskova J., Park P.C., et al. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential Giemsa banding and spectral karyotyping. Mol Diagn 5 (2000) 23-32
36. Vukovic B, Beheshti B, Park PC, et al. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotypic evolution in prostate cancer. Cytogenet Genome Res; in press.
37. Popescu N.C. Genetic alterations in cancer as a result of breakage at fragile sites. Cancer Lett 192 (2003) 1-17
38. Glover T.W. Common fragile sites. Cancer Lett 232 (2006) 4-12
39. Glover T.W., Arlt M.F., Casper A.M., et al. Mechanisms of common fragile site instability. Hum Mol Genet 14 Spec No. 2 (2005) R197-R205
40. Ferber M.J., Eilers P., Schuuring E., et al. Positioning of cervical carcinoma and Burkitt lymphoma translocation breakpoints with respect to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet 154 (2004) 1-9
41. Holschneider C.H., Baldwin R.L., Tumber K., et al. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer. Clin Cancer Res 11 (2005) 5756-5763
42. Yuan B.Z., Keck-Waggoner C., Zimonjic D.B., et al. Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res 60 (2000) 1049-1053
43. Miller C.T., Lin L., Casper A.M., et al. Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25 (2006) 409-418
44. Cremer T., Cremer M., Dietzel S., et al. Chromosome territories-a functional nuclear landscape. Curr Opin Cell Biol 18 (2006) 307-316
45. Zinner R., Albiez H., Walter J., et al. Histone lysine methylation patterns in human cell types are arranged in distinct three-dimensional nuclear zones. Histochem Cell Biol 125 (2006) 3-19
46. Parada L.A., McQueen P.G., Munson P.J., et al. Conservation of relative chromosome positioning in normal and cancer cells. Curr Biol 12 (2002) 1692-1697
47. Guasconi V., Souidi M., and Ait-Si-Ali S. Nuclear positioning, gene activity and cancer. Cancer Biol Ther 4 (2005) 134-138
48. Cremer T., Kurz A., Zirbel R., et al. Role of chromosome territories in the functional compartmentalization of the cell nucleus. Cold Spring Harb Symp Quant Biol 58 (1993) 777-792
49. Haaf T., and Schmid M. Chromosome topology in mammalian interphase nuclei. Exp Cell Res 192 (1991) 325-332
50. Mai S., and Garini Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97 (2006) 904-915
51. Mai S., and Garini Y. Oncogenic remodeling of the three-dimensional organization of the interphase nucleus: c-Myc induces telomeric aggregates whose formation precedes chromosomal rearrangements. Cell Cycle 4 (2005) 1327-1331
52. Vermolen B.J., Garini Y., Mai S., et al. Characterizing the three-dimensional organization of telomeres. Cytometry A 67 (2005) 144-150
53. Louis S.F., Vermolen B.J., Garini Y., et al. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 102 (2005) 9613-9618
54. Lim G., Karaskova J., Beheshti B., et al. An integrated mBAND and submegabase resolution tiling set (SMRT) CGH array analysis of focal amplification, microdeletions, and ladder structures consistent with breakage-fusion-bridge cycle events in osteosarcoma. Genes Chromosomes Cancer 42 (2005) 392-403
55. Lim G., Karaskova J., Vukovic B., et al. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63. Cancer Genet Cytogenet 153 (2004) 158-164
56. Pandita A., Zielenska M., Thorner P., et al. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia 1 (1999) 262-275
57. Gisselsson D., Pettersson L., Hoglund M., et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 97 (2000) 5357-5362
58. Bayani J., Brenton J.D., Macgregor P.F., et al. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res 62 (2002) 3466-3476
59. Jones R.N. McClintock's controlling elements: the full story. Cytogenet Genome Res 109 (2005) 90-103
60. Shuster M.I., Han L., Le Beau M.M., et al. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28 (2000) 153-163
61. Selvarajah S., Yoshimoto M., Park P.C., et al. The breakage-fusion-bridge (BFB) cycle as a mechanism for generating genetic heterogeneity in osteosarcoma. Chromosoma 115 6 (2006) 459-467 [Epub 2006, August 9]
62. Gisselsson D., Gorunova L., Hoglund M., et al. Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer 91 (2004) 327-332
63. Gisselsson D., and Hoglund M. Connecting mitotic instability and chromosome aberrations in cancer-can telomeres bridge the gap?. Semin Cancer Biol 15 (2005) 13-23
64. Gisselsson D., Lv M., Tsao S.W., et al. Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma. Genes Chromosomes Cancer 42 (2005) 22-33
65. Shay J.W., and Wright W.E. Telomeres and telomerase: implications for cancer and aging. Radiat Res 155 (2001) 188-193
66. Gisselsson D. Chromosome instability in cancer: how, when, and why?. Adv Cancer Res 87 (2003) 1-29
67. Feinberg A.P., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
68. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 16 (2002) 6-21
69. Chen R.Z., Pettersson U., Beard C., et al. DNA hypomethylation leads to elevated mutation rates. Nature 395 (1998) 89-93
70. Eden A., Gaudet F., Waghmare A., et al. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300 (2003) 455
71. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat Rev Cancer 4 (2004) 143-153
72. Baylin S.B., and Ohm J.E. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction?. Nat Rev Cancer 6 (2006) 107-116
73. Fraga M.F., and Esteller M. Towards the human cancer epigenome: a first draft of histone modifications. Cell Cycle 4 (2005) 1377-1381
74. Lengauer C., Kinzler K.W., and Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci USA 94 (1997) 2545-2550
75. Rodriguez J., Frigola J., Vendrell E., et al. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66 (2006) 8462-9468
76. Xu G.L., Bestor T.H., Bourc'his D., et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402 (1999) 187-191
77. Dodge J.E., Okano M., Dick F., et al. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 280 (2005) 17986-17991
78. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 411 (2001) 366-374
79. Lindahl T., and Wood R.D. Quality control by DNA repair. Science 286 (1999) 1897-1905
80. Khanna K.K., and Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27 (2001) 247-254
81. Deng C.X., and Wang R.H. Roles of BRCA1 in DNA damage repair: a link between development and cancer. Hum Mol Genet 12 Spec No. 1 (2003) R113-R123
82. Kops G.J., Weaver B.A., and Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5 (2005) 773-785
83. Pihan G.A., and Doxsey S.J. The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol 9 (1999) 289-302
84. Andreassen P.R., Martineau S.N., and Margolis R.L. Chemical induction of mitotic checkpoint override in mammalian cells results in aneuploidy following a transient tetraploid state. Mutat Res 372 (1996) 181-194
85. Hollander M.C., and Fornace Jr. A.J. Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 21 (2002) 6228-6233
86. Skibbens R.V., and Hieter P. Kinetochores and the checkpoint mechanism that monitors for defects in the chromosome segregation machinery. Annu Rev Genet 32 (1998) 307-337
87. Skoufias D.A., Andreassen P.R., Lacroix F.B., et al. Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc Natl Acad Sci USA 98 (2001) 4492-4497
88. van Vugt M.A., and Medema R.H. Getting in and out of mitosis with Polo-like kinase-1. Oncogene 24 (2005) 2844-2859
89. Meraldi P., and Nigg E.A. The centrosome cycle. FEBS Lett 521 (2002) 9-13
90. Pihan G.A., Wallace J., Zhou Y., et al. Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res 63 (2003) 1398-1404
91. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat Rev Cancer 2 (2002) 815-825
92. Doxsey S. Duplicating dangerously: linking centrosome duplication and aneuploidy. Mol Cell 10 (2002) 439-440
93. 1. Mol Biol Cell 12 (2001) 1315-1328
94. Yoshimoto M., Joshua A.M., Chilton-Macneill S., et al. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 8 (2006) 465-469
95. Tomlins S.A., Rhodes D.R., Perner S., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
96. Hoglund M., Gisselsson D., Hansen G.B., et al. Ovarian carcinoma develops through multiple modes of chromosomal evolution. Cancer Res 63 (2003) 3378-3385
97. Hoglund M., Jin C., Gisselsson D., et al. Statistical analyses of karyotypic complexity in head and neck squamous cell carcinoma. Cancer Genet Cytogenet 150 (2004) 1-8
98. Duesberg P., Li R., Fabarius A., et al. The chromosomal basis of cancer. Cell Oncol 27 (2005) 293-318
99. Duesberg P., Li R., Fabarius A., et al. Aneuploidy and cancer: from correlation to causation. Contrib Microbiol 13 (2006) 16-44
100. Heng H.H., Bremer S.W., Stevens J., et al. Cancer progression by non-clonal chromosome aberrations. J Cell Biochem (2006)
101. Heng H.H., Liu G., Bremer S., et al. Clonal and non-clonal chromosome aberrations and genome variation and aberration. Genome 49 (2006) 195-204
102. Nowell P.C. The clonal evolution of tumor cell populations. Science 194 (1976) 23-28
103. Heim S., Mandahl N., and Mitelman F. Genetic convergence and divergence in tumor progression. Cancer Res 48 (1988) 5911-5916
104. Heim S., and Mitelman F. Cancer Cytogenetics. 2nd ed. (1995), Wiley-Liss Inc., New York
105. Heng H.H., Stevens J.B., Liu G., et al. Stochastic cancer progression driven by non-clonal chromosome aberrations. J Cell Physiol 208 (2006) 461-472
106. Li L., and Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66 (2006) 4553-4557
107. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7 (2006) 21-33
108. Lapidot T., Sirard C., Vormoor J., et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
109. Singh S.K., Clarke I.D., Terasaki M., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 63 (2003) 5821-5828
110. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
111. Park P.C., Selvarajah S., Bayani J., et al. Stem cell enrichment approaches. Semin Cancer Biol (2006) April 29 [Epub ahead of print]
112. Breivik J., and Gaudernack G. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 9 (1999) 245-254
113. Li R., Sonik A., Stindl R., et al. Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci USA 97 (2000) 3236-3241
114. Loeb L.A., Springgate C.F., and Battula N. Errors in DNA replication as a basis of malignant changes. Cancer Res 34 (1974) 2311-2321
115. Shih I.M., Zhou W., Goodman S.N., et al. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61 (2001) 818-822
116. Tomlinson I., and Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med 5 (1999) 11-12
117. Yang Y., Fruehauf J., Xiang S., et al. Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patients. Cell Cycle 5 (2006) 1443-1447
118. Moskovitz A.H., Linford N.J., Brentnall T.A., et al. Chromosomal instability in pancreatic ductal cells from patients with chronic pancreatitis and pancreatic adenocarcinoma. Genes Chromosomes Cancer 37 (2003) 201-206
119. Nowak M.A., Komarova N.L., Sengupta A., et al. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99 (2002) 16226-16231
120. Hernando E., Nahle Z., Juan G., et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430 (2004) 797-802
121. Lohmann D.R., and Gallie B.L. Retinoblastoma: revisiting the model prototype of inherited cancer. Am J Med Genet C Semin Med Genet 129 (2004) 23-28
122. Tijo H., and Levan A. The chromosomes of man. Hereditas 42 (1956) 1-6
123. Nowell P.C., and Hungerford D.A. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 25 (1960) 85-109
124. Rowley J.D. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243 (1973) 290-293
125. Mitelman F., Mertens F., and Johansson B. Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders. Genes Chromosomes Cancer 43 (2005) 350-366
126. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
127. Pollack J.R. Chromosome instability leaves its mark. Nat Genet 38 (2006) 973-974
128. Carter S.L., Eklund A.C., Kohane I.S., et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38 (2006) 1043-1048